Perinatology.  2017 Dec;28(4):184-186. 10.14734/PN.2017.28.4.184.

Trastuzumab Exposure during Pregnancy with Invasive Breast Cancer

Affiliations
  • 1Department of Surgery, Dankook University College of Medicine, Cheonan, Korea.
  • 2Department of Obstetrics and Gynecology, Dankook University College of Medicine, Cheonan, Korea. yundan76@dankook.ac.kr

Abstract

Trastuzumab is a monoclonal antibody used for the treatment of human epidermal growth factor receptor-2 positive breast cancer. There is a little information in the literature regarding the safe use of trastuzumab in pregnancy, although some reports suggest an increased risk of oligohydramnios. We present a case of woman on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infant.

Keyword

Breast cancer; Pregnancy; Trastuzumab

MeSH Terms

Breast Neoplasms*
Breast*
Epidermal Growth Factor
Female
Humans
Infant
Oligohydramnios
Pregnancy*
Trastuzumab*
Epidermal Growth Factor
Trastuzumab
Full Text Links
  • PN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr